CIK 0001702123 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in A6 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-23 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-09-23 | 6-K | FORM 6-K | 2026-09-23 |
| 2026-09-16 | SUPPL | SUPPL | |
| 2026-09-16 | F-10/A | F-10/A | |
| 2026-09-16 | 6-K | FORM 6-K | 2026-09-16 |
| 2026-09-15 | 6-K | FORM 6-K | 2026-09-14 |
| 2026-09-11 | 6-K | FORM 6-K | 2026-09-10 |
| 2026-09-10 | 6-K | FORM 6-K | 2026-09-10 |
| 2026-09-10 | F-X | F-X | |
| 2026-09-10 | F-10 | F-10 | |
| 2026-09-09 | 6-K | FORM 6-K | 2026-09-09 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-12 | 6-K | FORM 6-K | 2026-06-30 |
| 2026-08-05 | 6-K | FORM 6-K | 2026-08-05 |
| 2026-07-14 | 6-K | FORM 6-K | 2026-07-14 |
| 2026-07-09 | 6-K | FORM 6-K | 2026-07-09 |
| 2026-06-25 | 6-K | FORM 6-K | 2026-06-25 |
| 2026-06-23 | 6-K | FORM 6-K | 2026-06-23 |
| 2026-05-26 | 6-K | FORM 6-K | 2026-05-25 |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-14 | 6-K | FORM 6-K | 2026-05-14 |
| 2026-05-11 | 6-K | FORM 6-K | 2026-03-31 |
| 2026-05-07 | 6-K | FORM 6-K | 2026-05-07 |
| 2026-04-28 | 6-K | FORM 6-K | 2026-04-28 |
| 2026-04-14 | 6-K | FORM 6-K | 2026-04-14 |
Forms on file (last 1,000): 6-K 131, SUPPL 10, F-X 5, F-10 5, D 5, F-10/A 4, SC 13G/A 4, SCHEDULE 13G/A 3. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CRDL (0.002 USD), /gw/filings/filings?ticker=CRDL&form=8-K, /gw/filings/facts?ticker=CRDL&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange